Executive Conference Corporation
The mission of ECC Webinars is to provide the pharmaceutical, biotech, and medical device industries with leading edge and informative webinars led by experts in their fields, fostering a stronger knowledge base in the workforce.
"The Difference is Distictive"
Webinars
Archived ECC Webinars
| ECC # | DATE | TITLE | Instructor(s) |
|---|---|---|---|
| ECC-718 | 2026-01-21 | Process Simulation Testing for Aseptically Filled Products; An In-depth Examination of the Latest Product Sterility Assurance Levels Prescribed by GMPs | Barry A. Friedman Ph.D |
| ECC-716 | 2026-01-20 | Sterile Filtration of Pharmaceutical Products – Validation and Regulatory Requirements | Roger Cowan |
| ECC-717 | 2026-01-15 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-715 | 2026-01-13 | VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE) | Barry A. Friedman Ph.D |
| ECC-713 | 2025-12-18 | Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter | Barry A. Friedman Ph.D |
| ECC-712 | 2025-12-16 | USP 61/62 Microbiological Enumeration & Examination of Non-Sterile Products | Barry A. Friedman Ph.D |
| ECC-714 | 2025-12-11 | HVAC and GMP Environmental Control for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-711 | 2025-12-10 | Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile ProductionFDA and ICH Expectations and Guidance | Barry A. Friedman Ph.D |
| ECC-710 | 2025-12-03 | Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing” | Barry A. Friedman Ph.D |
| ECC-705 | 2025-11-20 | MICROBIOLOGY FOR THE NON-MICROBIOLOGIST – AND THE MICROBIOLOGIST WHO DESIRES A GMP MICROBIOLOGICAL REFRESHER | Barry A. Friedman Ph.D |
| ECC-709 | 2025-11-13 | Sterile Filtration of Pharmaceutical Products – Validation and Regulatory Requirements | Roger Cowan |
| ECC-703 | 2025-11-12 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-702 | 2025-11-05 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-708 | 2025-11-04 | Hot Topics in the Cleanroom Industry, Biodecontamination of RABS and Isolators, Materials Transfer and Disinfectant Field Trials | Jim Polarine |
| ECC-701 | 2025-10-29 | VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE) | Barry A. Friedman Ph.D |
| ECC-707 | 2025-10-23 | GMP Environmental Monitoring for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-700 | 2025-10-22 | THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085> | Barry A. Friedman Ph.D |
| ECC-699 | 2025-10-16 | Annual Laboratory Microbiology Training | Barry A. Friedman Ph.D |
| ECC-698 | 2025-10-08 | Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter | Barry A. Friedman Ph.D |
| ECC-697 | 2025-09-16 | USP 61/62 Microbiological Enumeration & Examination of Non-Sterile Products | Barry A. Friedman Ph.D |
| ECC-693 | 2025-09-11 | Leveraging AI in Clinical Trials: From Protocol Design to Regulatory Readiness | Dr. Jenna Levenson |
| ECC-696 | 2025-09-10 | Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile ProductionFDA and ICH Expectations and Guidance | Barry A. Friedman Ph.D |
| ECC-695 | 2025-09-09 | FDA Contract Manufacturing Arrangements for Drugs: Quality Agreements - Their Relationship to Microbiological Issues | Barry A. Friedman Ph.D |
| ECC-706 | 2025-09-04 | Pharmaceutical Compressed Air - Quality GMP Standards and Requirements | Roger Cowan |
| ECC-694 | 2025-09-03 | Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing” | Barry A. Friedman Ph.D |
| ECC-679 | 2025-08-27 | Hot Topics in the Cleanroom Industry, Biodecontamination of RABS and Isolators, Materials Transfer and Disinfectant Field Trials | Jim Polarine |
| ECC-692 | 2025-08-26 | Development of a Steam Autoclave Sterilization Validation Plan | Barry A. Friedman Ph.D |
| ECC-677 | 2025-08-14 | HVAC and GMP Environmental Control for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-691 | 2025-08-13 | MICROBIOLOGY FOR THE NON-MICROBIOLOGIST – AND THE MICROBIOLOGIST WHO DESIRES A GMP MICROBIOLOGICAL REFRESHER | Barry A. Friedman Ph.D |
| ECC-690 | 2025-08-07 | Process Simulation Testing for Aseptically Filled Products | Barry A. Friedman Ph.D |
| ECC-680 | 2025-08-06 | CMO Supplier Quality Agreements – How to Comply with new FDA and EU Guidelines for Contract Drug Manufacture | Roger Cowan |
| ECC-689 | 2025-08-05 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-688 | 2025-07-24 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-678 | 2025-07-22 | A Risk Assessment Approach to Address Fungal Spore Contamination in a Cell and Gene Therapy Cleanroom | Jim Polarine |
| ECC-687 | 2025-07-17 | VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE) | Barry A. Friedman Ph.D |
| ECC-686 | 2025-07-15 | Risk Management and The New General Chapter, USP<60>, Burkholderia cepacia | Barry A. Friedman Ph.D |
| ECC-685 | 2025-07-10 | USP 61/62 Microbiological Enumeration & Examination of Non-Sterile Products | Barry A. Friedman Ph.D |
| ECC-667 | 2025-06-18 | Cleaning Classified Rooms to meet EU Annex 1 requirements | Jim Polarine,Dan Klein |
| ECC-684 | 2025-06-17 | THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085> | Barry A. Friedman Ph.D |
| ECC-676 | 2025-06-11 | Sterile Filtration of Pharmaceutical Products – Validation and Regulatory Requirements | Roger Cowan |
| ECC-683 | 2025-06-10 | Annual Laboratory Microbiology Training | Barry A. Friedman Ph.D |
| ECC-682 | 2025-06-04 | Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile ProductionFDA and ICH Expectations and Guidance | Barry A. Friedman Ph.D |
| ECC-681 | 2025-06-03 | Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter | Barry A. Friedman Ph.D |
| ECC-675 | 2025-05-21 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-674 | 2025-05-14 | Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing” | Barry A. Friedman Ph.D |
| ECC-673 | 2025-05-07 | Process Simulation Testing for Aseptically Filled Products | Barry A. Friedman Ph.D |
| ECC-655 | 2025-05-01 | Pharmaceutical Compressed Air - Quality GMP Standards and Requirements | Roger Cowan |
| ECC-672 | 2025-04-30 | GMP Environmental Monitoring for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-669 | 2025-04-29 | MICROBIOLOGY FOR THE NON-MICROBIOLOGIST – AND THE MICROBIOLOGIST WHO DESIRES A GMP MICROBIOLOGICAL REFRESHER | Barry A. Friedman Ph.D |
| ECC-670 | 2025-04-24 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| Page: | 1 | 2 | | |||